Novartis - Medicow
About us  |  Why use us?  |  Press  |  Contact us

 

Topic: Novartis



  
 BW Online May 26, 2003 Novartis
Novartis' boss is an unusual mix, an aggressive manager who still keeps something of the gentle bedside manner he developed as a general practitioner.
There, Novartis was a midtier player -- certainly no match for Merck (MRK) & Co. or Pfizer (PFE) Inc. But Vasella, a physician himself, devoted every penny he could find to marketing and research and took the world by surprise in May, 2001, with Glivec, one of the most effective new cancer therapies going.
"Novartis shows other drugmakers that these little niches can be extraordinarily valuable scientifically, as well as commercially feasible," says Dr. George D. Demetri, director of the sarcoma center at Harvard Medical School's Dana-Farber Cancer Institute in Boston.
http://www.businessweek.com/magazine/content/03_21/b3834021_mz044.htm   (2391 words)

  
 IFPMA Health Initiatives: Participating Companies: Novartis
Novartis donates intraocular lenses to NGOs for cataract surgery for patients with inadequate means in developing countries.
In Sri Lanka, the Novartis Foundation supports the efforts of the Sarvodaya Shramadana Movement that is active in over 12,000 villages, applying a holistic and integrated approach to rural village development.
Thus an adequate teaching and learning environment will contribute substantially to improved medical expertise, which in turn is needed to improve the overall health situation of the population, especially in rural areas.
http://www.ifpma.org/Health/participate/health_novartis_part.aspx   (447 words)

  
 Novartis Care Plan
Novartis is offering valuable savings on its prescription medications to fit the needs of low income patients enrolled in Medicare without prescription drug coverage.
Novartis believes doctors and patients should be able to choose the best medicines available.
Novartis has a comprehensive and flexible prescription savings plan that offers help to a broad range of lower income patients enrolled in Medicare without presrciption drug coverage.
http://www.careplan.novartis.com/about.html   (799 words)

  
 Novartis Oncology - Novartis Patient Assistance
Novartis Oncology offers one of the most generous and far-reaching international patient assistance programs ever developed for a breakthrough cancer therapy.
The following are just 2 examples of the Novartis Oncology commitment to patients and their families.
The program provides drug at no cost to qualified patients who are not insured or reimbursed and have no other financial recourse.
http://www.novartisoncology.com/page/patients.jsp   (248 words)

  
 Privacy Policy - Novartis.com
In contrast, where Novartis believes that certain product, health, or other information is of importance to you it reserves the right to inform you by e-mail whilst giving you the choice of opting out of such service.
Spamming is defined as sending unsolicited e-mails, usually of a commercial nature, in large numbers and repeatedly to individuals with whom the sender has had no previous contact or who have declined to receive such communications.
Access to personal data is restricted to those employees who have a need to use the data and who have been trained to handle such data properly and observe strict standards of confidentiality.
http://www.milbemite.novartis.us/privacy_policy.shtml   (1230 words)

  
 Novartis Consumer Health
Scientists at Novartis Animal Health's research laboratories strive for improved animal care by searching for new therapies and novel delivery technologies.
In Australia, we are at the forefront of international animal health research and development, boasting a key worldwide research facility which is actively seeking solutions to the highly diverse diseases and needs of animals.
New molecules are identified by screening novel compounds from our own research, through external collaborations, and by building on Novartis' vast experience in human medicine.
http://www.novartis.com.au/consumer_health.html   (457 words)

  
 Bloomberg.com: Europe
Novartis repeated that its experimental drug ICL670 was effective at removing excess iron from the blood in a late-stage study originally presented last month.
In November, Novartis withdrew an application for European Union approval of Prexige, an experimental painkiller similar to Merck and Co.'s Vioxx, as regulators review the safety of such drugs.
Sales at Sandoz grew 5 percent during 2004, compared with 15 percent for Novartis's brand-name drugs.
http://www.bloomberg.com/apps/news?pid=10000085&sid=aM5wz760qZm0&refer=europe   (1096 words)

  
 Novartis to Acquire North American OTC Brand Portfolio from Bristol-Myers Squibb
Excedrin provides strong platform to develop the business Excedrin, a triple combination of acetaminophen, aspirin and caffeine, is an analgesic known for its potency and strong positioning for relief as "The Headache Medicine," a condition that is one of the most important uses of OTC analgesics.
These forward-looking statements speak only as of the date of this press release and no undertaking has been made to update or revise them if there are changes in expectations or if any events, conditions or circumstances on which any such forward looking statement is based.
It is No. 2 in the segment for OTC headache treatments with a 96% consumer awareness.
http://www.primezone.com/newsroom/news.html?d=81743   (793 words)

  
 Clinical Trials at Novartis - Information about Novartis Clinical Trials
Novartis recommends that you consult your doctor before participating in a clinical trial.
Our goal is to help you make an educated decision about participating in a clinical trial and to help you understand the clinical trial process.
Sign up and receive information about Novartis clinical trials in your health-related areas of interest.
http://www.novartisclinicaltrials.com   (145 words)

  
 Welcome to our Foundation - Novartis Foundation for Sustainable Development
The Novartis Symposium 2005 gives an opportunity to meet people with a vision and drive who represent social and humanitarian movements.
In the context of our work, we increasingly incorporate scientific findings and practical experience into political debate, in addition to legitimate points of view from the private sector.
This allows us to develop and strengthen constructive working relations with very different interest groups.
http://www.foundation.novartis.com/index.htm   (423 words)

  
 Welcome to Novartis India Limited - Pharmaceuticals
Novartis offers hope to epileptic patients through Tegrital which has a wide range of activity and is arguably one of the most useful anti - epileptic drugs currently available.
Exelon helps maintain and improve the patients mental and functional abilities, preserving and sometimes restoring his independence and dignity.
Novartis with Exelon offers a new line of treatment for Alheizemers.
http://www.in.pharma.novartis.com   (548 words)

  
 Novartis Institutes for BioMedical Research - Novartis.com
Novartis also announced significant progress in other aspects of its industry-leading pipeline, which is comprised of 75 projects in clinical development.
The survey measured attributes such as treating associates with respect, being an innovative leader, and having a clear vision of where the company is heading.
© 2004 Novartis Institutes for BioMedical Research, Inc.
http://www.nibr.novartis.com   (126 words)

  
 Welcome to Novartis UK - Novartis.co.uk
Novartis Consumer Health is comprised of the Business Units:  Over the Counter (OTC), Animal Health, Medical Nutrition, Infant and Baby and CIBA Vision.
Novartis Pharmaceuticals focuses on the following therapeutic areas:
Novartis is a world leader in the research and development of products to protect and improve health and well being.
http://www.novartis.co.uk   (228 words)

  
 Novartis "overweight" newratings.com
LONDON, November 14 (newratings.com) — Analysts at JP Morgan issue an "overweight" rating on Novartis (NVS).
Novartis quote - chart - all headlines - analyst actions
The analysts mention that the company’s products have limited exposure to patent risks, as compared to its peers in the healthcare industry.
http://www.newratings.com/analyst_news/article_353862.html   (333 words)

  
 The New York Times: Search > Topic: NOVARTIS
Novartis Seeks To Take Over A Drug Maker For $4 Billion
INTERNATIONAL BUSINESS; Novartis Buys the Rights To Develop a Lung Drug
Vasella has steered Novartis, the fifth-largest drug company in the world, to...
http://query.nytimes.com/search/query?ppds=org&v1=NOVARTIS&fdq=19960101&td=sysdate&sort=newest&ac=NOVARTIS&rt=1,des,org,per,geo   (655 words)

  
 Novartis Nutrition U.S. - Consumer Health and Nutritional Needs
Novartis Medical Nutrition is one of six key businesses found within the Consumer Health area of Novartis.
Novartis Medical Nutrition U.S. - Article List - Critical Care / Surgery
Privacy Policy Your Personal Information Novartis Medical Nutrition will not collect any personally identifiable information about you except when you specifically...
http://search.novartis.com/local/query.html?site=www.novartisnutrition.com/us/home&qp=url:www.novartisnutrition.com/us/&qt=&submit.x=12&submit.y=9   (405 words)

  
 Welcome to Novartis (Thailand) Limited
Besides marketing, sales & distribution Novartis is also active in the area of clinical research in Thailand.
GIPAP program - provided medicine at no cost to 325 advanced stage Chronic Myeloid Leukemia (CML), chronic CML, and Gastrointestinal Stromal Tumours (GIST) patients (YTD Feb 05), valued at USD 9.0 million or THB 360,000,000 for 2004.
Established 34 years ago, Novartis Thailand represents all of Novartis's main business activities with a focus on prescription pharmaceuticals (208 staff), consumer health (104 staff : Animal Health, Sandoz, OTC, Infant&Baby and CIBA Vision).
http://www.th.novartis.com   (375 words)

  
 Novartis Institute for Tropical Diseases - Mission - NITD
Novartis is not responsible for the content or practices of any non-Novartis site.
In those developing countries where these diseases are endemic, the Novartis Group intends to make treatments readily available and without profit to poor patients.
With the founding of the NITD, Novartis intends to advance medical research on infectious and parasitic diseases that affect so many people in the developing world.
http://www.nitd.novartis.com/mission/index.shtml   (368 words)

  
 Novartis Prize for Diabetes
Novartis is a global leader in the Life Sciences, committed to improving health and well-being through the development of innovative products.
The development of complementary therapies to improve measures of metabolic control continues to be a major focus of Novartis' research efforts, and all curative technologies (cell therapy and transplantation) - including the treatment of diabetic complications - are of interest to Novartis Pharma AG.
Continuing development efforts include programs to develop drug therapies that improve insulin action, to increase glucose disposal in the muscle, to limit its production in the liver and to improve the kinetics of insulin secretion.
http://www.diabetesaward.novartis.com/public/commitment.htm   (200 words)

  
 Diabetes - Information for Healthcare, Media Professionals and the General Public
Novartis recognises outstanding achievement in clinical research, education and clinical practice in the field of diabetes mellitus.
Information and Resources concerning Starlix and the treatment of Type 2 Diabetes.
Navigator is the largest diabetes prevention study and the only trial targeted at demonstrating that the risk of cardiovascular disease can be reduced in people with impaired glucose tolerance.
http://www.diabetesandhealth.com   (148 words)

  
 Novartis, an innovative healthcare products company - Novartis.com
Novartis is raising awareness about osteoporosis with the IOF.
New research shows benefits of Elidel® in eczema patients who require an alternative to conventional steroid treatment
Bagamoyo, Tanzania, October 17, 2005 – International experts at a symposium sponsored by the Novartis Institute for Tropical Diseases (NITD) are meeting to review advances in research on tuberculosis (TB) therapies.
http://www.novartis.com   (266 words)

  
 Novartis Moving Worldwide Research Headquarters to Boston Area - Site Selection Online Insider
Last year alone, Novartis' drug division spent some $2.2 billion in research and development.
Novartis, however, is the first major drug company to base its global research in Cambridge.
Aredia, an intravenous treatment for skeletal complications from cancer, is one of the 15 drugs that Novartis has brought to market in the last two years - the highest number any drug maker recorded during that span.
http://www.conway.com/ssinsider/bbdeal/bd020520.htm   (1114 words)

  
 Novartis Australia home page
This research not only assures the effectiveness of the company's current range of treatments, but secures the promise of improving health for the future.
Our businesses include - pharmaceuticals, consumer health, generics, eye-care, and animal health - and enable us to help people right around Australia deal with the challenges of conditions as diverse as breast cancer, mental illness, menopause and fungal infections.
Novartis Australia is a leading provider of innovative solutions to improve health and well-being.
http://www.novartis.com.au   (152 words)

  
 Novartis Pharma - Novartis Pharmaceuticals
Novartis has taken a leadership role in improving the access of low-income patients to the medicines they need.
Through programs like the Novartis Patient Assistance Program, Together Rx Access, and the Partnership for Prescription Assistance, Novartis helps thousands of patients every day.
Novartis Group companies within the US have immediately offered help in the form of product and cash donations to support the work of government authorities and relief organizations in all the effected states.
http://www.pharma.us.novartis.com   (235 words)

  
 Welcome to Novartis Animal Health - Novartis.com
Atopic dermatitis(AD) is one of the most common skin diseases of dogs.
Novartis Animal Health is dedicated to maintaining and improving the health and welfare of animals, both pets and food-producing animals.
Novartis Animal Health employs approximately 2200 people worldwide and is represented in almost 40 countries.
http://www.ah.novartis.com   (106 words)

  
 Novartis in the Philippines
"Novae Artes" is Latin and means "new skills", as the hallmark of Novartis is innovation and the development of new skill in all aspects of our activities
Novartis is one of the world leading companies with core businesses in Healthcare (Pharmaceuticals, Opthalmics and Animal Health) and Consumer Health (self-medication, Nutrition).
Novartis Consumer Health, with its famous leading brands Ovaltine and Gerber, is based in Pasig city.
http://www.ph.novartis.com   (223 words)

  
 Oligopoly Watch
It is also a leader in vision care with its Ciba Vision contact lenses.
It has a wide variety of prescription drugs treating everything from herpes to Alzheimer's disease.
The Pharmaceuticals group (64% of corporate income) includes a wide variety of drug therapies from oncology to dermatology to ophthalmology.
http://www.oligopolywatch.com/2004/04/05.html   (529 words)

  
 Novartis Transplant: Milestones In Transplantation
Although this piece may not reflect the current state of the art, Novartis believes that the basic scientific principles discussed within remain valid.
Since this piece was published, advances have been made in medicine.
© Novartis Pharmaceuticals Corporation 2002 All Rights Reserved.
http://www.novartis-transplant.com/medpro/symposia/milestones_in_TX.html   (1351 words)

  
 Novartis Prize for Diabetes
The candidate will be recognized for their clinical research, education and clinical practice and their impact in the field of diabetes mellitus.
The annual Novartis Prize in Diabetes (Long-Standing Achievement) is intended to recognize innovative patient-oriented research in the fields of physiology, pathophysiology or epidemiology of diabetes mellitus and its complications.
Nomination and seconding of the candidate must be by peers.
http://www.diabetesaward.novartis.com/public/long_standing.htm   (332 words)

  
 Novartis Animal Health US, Inc.
These companies trace their history to 1758 when Johann Rudolph Geigy-Gemuseus began trading in "Materials, Chemicals, Dyes and Drugs of All Kinds" in Basel, Switzerland.
Novartis Animal Health is dedicated to maintaining and improving the health and welfare of animals, both pets and food-producing animals.
Novartis Animal Health has three businesses: Pet Health, Livestock Health and Aqua Health.
http://livestock.novartis.com/history.html   (349 words)

  
 [No title]
"The recommendation by the independent monitoring board to continue the Phase III program, and the investigator assessment of progression encourage us to further explore the potential benefit of PTK/ZK in patients suffering from metastatic colorectal cancer and other cancers," said David Epstein, CEO of Specialty Medicines and president of Novartis Oncology.
Novartis AG (NYSE: NVS) is a world leader in pharmaceuticals and consumer health.
Novartis Pharma AG and Schering AG announced today that the analysis of progression free survival (PFS) as assessed by central radiology review in the CONFIRM 1 trial with the investigational drug PTK/ZK did not achieve statistical significance.
http://dominoext.novartis.com/NC/NCPRRE01.nsf/44aff02a639be034c1256b4b007b5f4d/a9455779de83d591c1256fca0081816e?OpenDocument   (722 words)

  
 Medical Careers - Novartis Pharmaceuticals
At Novartis, our focus is clear, our purpose defined.
The latest press releases on Novartis products, clinical trials, and the diseases and conditions we treat are available to members of the press.
Novartis strives to be an industry leader, recognized for valuing diversity as a critical component of a high performance culture.
http://www.pharma.us.novartis.com/careers/index.jsp   (132 words)

  
 Career center for job seekers - Novartis.com
Read about the experiences that make Novartis a great place to work from current Novartis employees.
Please select the country of your choice in the right navigation and search the vacancies available in that country, and apply using the application form available.
Your data will be entered into our database and you will be contacted if your profile matches an available position.
http://www.novartis.com/careers/en/index.shtml   (338 words)

  
 Eye Health – Novartis Ophthalmics
Learn more about the eye conditions and surgeries that Novartis products are used for
Learn how to care for your own and your children's eyes, and what tests they may use during an eye exam.
Read the latest news and announcements on the products, diseases and conditions that matter most to you…
http://www.us.novartisophthalmics.com   (118 words)

  
 Novartis Pharmaceuticals Canada Inc. - Home Page
Get quick access to any of our products' official prescribing information documents.
Innovative, once-a-day oral formulation addresses unmet medical need for iron overload patients
Novartis to show strong support and participation in the Run for the Cure through fundraising and employee participation in support of Canadian Breast Cancer Foundation.
http://www.pharma.ca.novartis.com/e/main.shtml   (279 words)

  
 Novartis in licensing deal on Hep C drug - Boston.com - Europe - News
Novartis obtains the right to develop, manufacture and commercialize the drug called ANA975 -- currently in Phase I trials -- to treat chronic hepatitis C, as well as to develop it for other indications, including hepatitis B infection.
The bank argued that Novartis had underperformed Roche this year and that the market perception of Novartis was changing, helped by growing expectations of positive news from the Basel-based firm.
Novartis in licensing deal on Hep C drug
http://www.boston.com/news/world/europe/articles/2005/06/02/novartis_in_licensing_deal_on_hep_c_drug   (382 words)

  
 Novartis AG - Fact Sheet - Hoover's
Although it's based in Switzerland, Novartis has been aggressive in attacking illnesses.
Novartis' consumer health unit includes such brands as Ex-Lax, Maalox, and Theraflu.
Novartis is also the proud parent of the Gerber baby.
http://www.hoovers.com/novartis/--ID__52941--/free-co-factsheet.xhtml   (303 words)

  
 Welcome to the Novartis Institute for Tropical Diseases - NITD
The Novartis Institute for Tropical Diseases (NITD) is a small-molecule drug discovery research institute dedicated to finding new drugs for the treatment of tropical diseases.
Novartis believes in the importance of a long-term commitment to helping reduce this global disease burden and thereby improving the prosperity and health of populations of developing nations.
Dengue fever and tuberculosis were collectively selected as the diseases on which to focus, with the possibility to expand to other disease areas in later years.
http://www.nitd.novartis.com/index.shtml   (217 words)

  
 [No title]
For Novartis, the pharmaceutical giant that takes its name from that term, the key to success is found in both developing new arts and leveraging previous experience.
A world leader in the research and development of products to protect and improve health and well-being.
Documentum gives all employees the opportunity to rapidly learn what their colleagues at other organizations and sites knew, coordinate ongoing research activity, and standardize on a common documentation system for all types of documents — all since merging the knowledge of the two patent organizations into a common repository.
http://www.documentum.com/customer_success/success/novartis.htm   (829 words)

  
 Novartis Corporation
With a heritage stretching back over two centuries, Novartis today is a world leader in healthcare with core businesses in pharmaceuticals, consumer health, genetics, eye-care and animal health.
One of the world's leading healthcare companies, Novartis' dedication to scientific research, imagination, and new technologies has led to the creation of thousands of ground-breaking products and services in the areas of pharmaceuticals, nutrition, eye-care and animal health.
The menopause is also called "the change life"
http://www.ie.novartis.com   (323 words)

  
 Novartis - Wikipedia, the free encyclopedia
There are indicia which point to the commercialization of genetically modified ingredients in Novartis' products, at least in Spain (source: Greenpeace Spain).
Novartis was created in 1996 from the merger of CIBA-Geigy and Sandoz Laboratories, both Swiss companies with long individual histories.
Critics of the agreement were concerned that the agreement would diminish academic objectivity or that it would lead to the commercialization of genetically modified plants.
http://en.wikipedia.org/wiki/Novartis   (215 words)

  
 US.NovartisOncology.com - Understanding Cancer Overview
Novartis Oncology offers treatments for cancers that range from breast cancer to leukemia to bone cancer to carcinoid tumors.
Here you can find important questions to ask your doctor
http://www.us.novartisoncology.com/info/understanding/index.jsp   (173 words)

  
 Novartis Slims Down Insecticide Product Line -- Agrow, February 09, 1998
One such area of investigation is its potential use as a nematicide.
Novartis has also considered its other products in coming to this decision.
Despite their importance in some countries, these products have decreasing market potential, Novartis believes.
http://www.pmac.net/novartis.htm   (1435 words)

  
 Novartis Corporation
As a leading healthcare company, Novartis is dedicated to improving health and quality of life through innovative products and services in the areas of pharmaceuticals, nutrition, eye care and animal health.
Novartis is formed from the merger of Sandoz and Ciba Geigy in 1997.
http://www.sg.pharma.novartis.com   (59 words)

  
 Novartis Animal Health US, Inc. - cattle diseases, swine diseases, equine diseases, cattle health, bovine respiratory ...
Novartis Animal Health US, Inc. - cattle diseases, swine diseases, equine diseases, cattle health, bovine respiratory disease (BRD), bovine viral diarrhea (BVD), calf scours, west nile virus treatment for horses, hemorrhagic bowel syndrome, herd health program, leptospirosis in cattle
Use the menu at left to learn more about specific animal health problems and the solutions available through a wide range of Novartis commercial and custom products.
Learn about Novartis Animal Health companion animal products for maintaining and improving the health and welfare of pets.
http://www.livestock.novartis.com   (253 words)

  
 Novartis - Corporate Profiles
Novartis has a better understanding of the cultural sensibilities of European mentality and therefore has better protected itself from media.
This Company profile offers only a bird's eye view of the activities of Novartis.
Through its name, signature and general PR texts, Novartis focuses people's attention on its new skills, expertise and research.
http://www.groundup.org/novartis/intro.htm   (551 words)

  
 Prevent motion sickness with clinically proven motion sickness patches, Transderm Scop
For more information on Novartis and other Novartis products, see Novartis.com.
Not for children or people who have or have had glaucoma (increased pressure in the eyeball), have difficulty urinating, or an allergy to the active ingredient, scopolamine or other belladonna alkaloids.
Your use of this website is subject to the terms of our Legal Statement and Privacy Policy.
http://www.transdermscop.com   (161 words)

  
 Welcome to Petwellness - Novartis Animal Health US, Inc.
Novartis Animal Health US, Inc. is not responsible for the content or practices of any non-Novartis Animal Health US, Inc. site.
Welcome to Petwellness - Novartis Animal Health US, Inc.
Let Novartis Animal Health US, Inc. help you stay on top of your pet's medication cycle with monthly e-mail reminders!
http://www.petwellness.com   (190 words)

  
 Fortekor - Novartis.com
Oral tablet for the treatment of heart failure in dogs and chronic renal insufficiency in cats
This information summarizes the current status of our knowledge and may differ from the legally binding, country specific use instructions provided with the product.
Novartis Animal Health Inc. is not liable for damages or injury caused by the use of its products different from those specified on the pack label.
http://www.ah.novartis.com/products/en/cab/fortekor.shtml   (990 words)

  
 NOVARTIS BREAKS PROMISE: ITS GERBER BABY FOOD CONTAINS MASSIVE AMOUNTS OF GENETICALLY ENGINEERED SOYA
Quantitative analysis has not yet been carried out for these products.
This was reiterated by Novartis US spokesperson Al Piergallini, who was quoted in the Wall Street Journal Europe of 30 July 1999 saying: “I want our mothers to be comfortable“.
In the past Novartis repeatedly declared it would not use GMOs in its food products.
http://archive.greenpeace.org/pressreleases/geneng/2001aug21.html   (599 words)

 About us   |  Why use us?   |  Press   |  Contact us

 Copyright © 2006 Medicow.com Usage implies agreement with terms.